COR Cencora, Inc. Common Stock
Cencora, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Devamını oku
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
COR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
COR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar |
|---|---|
| 15 Mayıs 2026 | $0,6000 |
| 13 Şubat 2026 | $0,6000 |
| 14 Kasım 2025 | $0,6000 |
| 15 Ağustos 2025 | $0,5500 |
| 16 Mayıs 2025 | $0,5500 |
| 14 Şubat 2025 | $0,5500 |
| 15 Kasım 2024 | $0,5500 |
| 09 Ağustos 2024 | $0,5100 |
| 09 Mayıs 2024 | $0,5100 |
| 08 Şubat 2024 | $0,5100 |
| 10 Kasım 2023 | $0,5100 |
| 10 Ağustos 2023 | $0,4850 |
| 11 Mayıs 2023 | $0,4850 |
| 09 Şubat 2023 | $0,4850 |
| 10 Kasım 2022 | $0,4850 |
| 12 Ağustos 2022 | $0,4600 |
| 13 Mayıs 2022 | $0,4600 |
| 11 Şubat 2022 | $0,4600 |
| 01 Aralık 2021 | $1,2700 |
| 12 Kasım 2021 | $0,4600 |
COR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 5 25,0%
- Al 10 50,0%
- Tut 5 25,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
12 analist · 2026-08-13Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Eylül 2026 | $4.48 | $4.39 | 0.09% |
| 30 Haziran 2026 | $4.48 | $4.39 | 0.09% |
| 31 Mart 2026 | $4.75 | $4.86 | -0.11% |
| 31 Aralık 2025 | $4.08 | $4.08 | 0.00% |
| 30 Eylül 2025 | $3.84 | $3.82 | 0.02% |
| 30 Haziran 2025 | $4.00 | $3.88 | 0.12% |
| 31 Mart 2025 | $4.42 | $4.15 | 0.27% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Nakit Akışı 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Büyüme Oranları 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Gelir Tablosu 15
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Bilanço 27
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Nakit Akışı 17
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Kârlılık 8
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Verimlilik 3
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Gelir | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Brüt Kâr Marjı % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Faaliyet Kâr Marjı % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Net Gelir | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| Seyreltilmiş Hisse Başı Kâr | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Bilanço
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Cari Oran | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Cari Oran | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Nakit Akışı
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Son Haberler Bu şirketten bahseden son manşetler
- IYK, MCK, CTVA, COR: ETF Outflow Alert
- Cuma 5/29 İçeriden Bilgili Alım Raporu: SCHW, COR
- Cencora (COR) Sağlık Sektöründe Lider Olarak Yükseliyor: Güçlü Temeller ve Stratejik Yeniden Değerlendirme
- Cencora 2. Çeyrek Kazanç Çağrısı Önemli Noktaları
- Cencora Inc 2. Çeyrek 26 Kazanç Konferans Görüşmesi 8:30 ET
- Cencora'nın Kazanç Açıklaması Öncesinde Bilmeniz Gerekenler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 1.489 dosya · $31.4B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 102 (-56 önceki Ç'ye göre) | 172 (+41 önceki Ç'ye göre) | 434 (-101 önceki Ç'ye göre) | 595 (+65 önceki Ç'ye göre) | +8.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.502.993.290 | 12.378.943 | 11,15% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.719.934.713 | 9.611.756 | 8,66% | Hisse senetleri |
| STATE STREET CORP | $2.624.351.709 | 9.273.983 | 8,35% | Hisse senetleri |
| Walgreens Boots Alliance, Inc. | $2.240.779.050 | 7.473.000 | 7,13% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.358.112.555 | 4.819.419 | 4,32% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $1.231.165.897 | 4.350.717 | 3,92% | Hisse senetleri |
| FMR LLC | $850.228.724 | 3.004.554 | 2,71% | Hisse senetleri |
| NORGES BANK | $700.042.999 | 2.473.825 | 2,23% | Hisse senetleri |
| Capital Research Global Investors | $560.283.987 | 1.979.942 | 1,78% | Hisse senetleri |
| Carmignac Gestion | $494.462.712 | 1.747.363 | 1,57% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483.772.138 | 1.709.563 | 1,54% | Hisse senetleri |
| Mawer Investment Management Ltd. | $421.312.792 | 1.488.843 | 1,34% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $410.282.013 | 1.449.862 | 1,31% | Hisse senetleri |
| CITADEL ADVISORS LLC | $347.541.038 | 1.228.147 | 1,11% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $338.738.459 | 1.197.038 | 1,08% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $315.929.430 | 1.116.828 | 1,01% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313.668.332 | 1.108.447 | 1,00% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $313.605.793 | 1.108.226 | 1,00% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294.327.781 | 1.040.101 | 0,94% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $293.610.144 | 1.037.565 | 0,93% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $268.966.547 | 950.479 | 0,86% | Hisse senetleri |
| LAZARD ASSET MANAGEMENT LLC | $261.088.180 | 922.638 | 0,83% | Hisse senetleri |
| Caisse de depot et placement du Quebec | $258.709.937 | 914.234 | 0,82% | Hisse senetleri |
| Boston Partners | $231.295.970 | 817.358 | 0,74% | Hisse senetleri |
| National Pension Service | $208.758.025 | 737.713 | 0,66% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $208.660.680 | 737.369 | 0,66% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $205.281.694 | 653.472 | 0,65% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $180.668.066 | 644.564 | 0,58% | Hisse senetleri |
| Burgundy Asset Management Ltd. | $174.893.972 | 599.753 | 0,56% | Hisse senetleri |
| Balyasny Asset Management L.P. | $172.225.024 | 608.612 | 0,55% | Hisse senetleri |
| Point72 Asset Management, L.P. | $171.131.023 | 604.746 | 0,54% | Hisse senetleri |
| Assenagon Asset Management S.A. | $166.084.924 | 586.914 | 0,53% | Hisse senetleri |
| Squarepoint Ops LLC | $154.024.599 | 544.295 | 0,49% | Hisse senetleri |
| Swiss National Bank | $147.506.155 | 521.260 | 0,47% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $141.101.751 | 498.628 | 0,45% | Hisse senetleri |
| Swedbank AB | $134.859.213 | 476.568 | 0,43% | Hisse senetleri |
| TimesSquare Capital Management, LLC | $132.589.070 | 422.070 | 0,42% | Hisse senetleri |
| Legal & General Group Plc | $129.674.734 | 458.247 | 0,41% | Hisse senetleri |
| RHUMBLINE ADVISERS | $123.138.883 | 435.151 | 0,39% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $120.449.305 | 425.646 | 0,38% | Hisse senetleri |
| BlackRock, Inc. | $119.463.969 | 422.164 | 0,38% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $117.740.633 | 416.074 | 0,37% | Hisse senetleri |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113.208.499 | 400.058 | 0,36% | Hisse senetleri |
| California Public Employees Retirement System | $110.655.367 | 391.036 | 0,35% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $105.342.134 | 372.260 | 0,34% | Hisse senetleri |
| SEB Asset Management AB | $104.030.095 | 367.624 | 0,33% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $101.511.435 | 358.723 | 0,32% | Hisse senetleri |
| VANGUARD GROUP INC | $100.694.421 | 298.133 | 0,32% | Hisse senetleri |
| Walleye Capital LLC | $98.419.595 | 347.797 | 0,31% | Hisse senetleri |
| MIZUHO MARKETS AMERICAS LLC | $96.213.200 | 340.000 | 0,31% | Hisse senetleri |
| JOHNSON INVESTMENT COUNSEL INC | $93.893.214 | 331.802 | 0,30% | Hisse senetleri |
| STOREBRAND ASSET MANAGEMENT AS | $93.049.484 | 328.820 | 0,30% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88.657.847 | 282.224 | 0,28% | Hisse senetleri |
| Cornerstone Investment Partners, LLC | $86.260.510 | 304.829 | 0,27% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85.771.238 | 303.100 | 0,27% | Alım opsiyonu |
| JONES FINANCIAL COMPANIES LLLP | $85.147.559 | 297.583 | 0,27% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $83.133.772 | 266.003 | 0,26% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81.593.038 | 288.335 | 0,26% | Hisse senetleri |
| FIL Ltd | $79.588.408 | 281.251 | 0,25% | Hisse senetleri |
| LPL Financial LLC | $76.804.992 | 271.415 | 0,24% | Hisse senetleri |
| TD Asset Management Inc | $76.770.210 | 271.292 | 0,24% | Hisse senetleri |
| BANK OF MONTREAL /CAN/ | $70.057.359 | 247.570 | 0,22% | Hisse senetleri |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69.812.864 | 246.706 | 0,22% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $68.792.155 | 243.099 | 0,22% | Hisse senetleri |
| CITADEL ADVISORS LLC | $68.622.650 | 242.500 | 0,22% | Alım opsiyonu |
| FIRST MANHATTAN CO. LLC. | $68.126.586 | 240.747 | 0,22% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $67.675.233 | 239.152 | 0,22% | Hisse senetleri |
| TREMBLANT CAPITAL GROUP | $67.203.788 | 237.486 | 0,21% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $64.886.066 | 229.296 | 0,21% | Hisse senetleri |
| EARNEST PARTNERS LLC | $63.127.461 | 223.081 | 0,20% | Hisse senetleri |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60.624.220 | 214.235 | 0,19% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $60.395.855 | 213.428 | 0,19% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $60.017.829 | 212.092 | 0,19% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59.924.694 | 211.763 | 0,19% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57.032.921 | 201.544 | 0,18% | Hisse senetleri |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52.864.060 | 186.812 | 0,17% | Hisse senetleri |
| BARCLAYS PLC | $51.304.557 | 181.301 | 0,16% | Hisse senetleri |
| Mitsubishi UFJ Trust & Banking Corp | $51.082.984 | 180.518 | 0,16% | Hisse senetleri |
| PFA Pension, Forsikringsaktieselskab | $50.217.651 | 177.460 | 0,16% | Hisse senetleri |
| MARSHALL WACE, LLP | $50.044.447 | 176.848 | 0,16% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $49.878.621 | 176.262 | 0,16% | Hisse senetleri |
| Sio Capital Management, LLC | $49.121.932 | 173.588 | 0,16% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48.634.175 | 162.136 | 0,15% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48.419.177 | 171.284 | 0,15% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47.513.047 | 151.248 | 0,15% | Hisse senetleri |
| AVIVA PLC | $47.242.096 | 166.945 | 0,15% | Hisse senetleri |
| Jefferies Financial Group Inc. | $46.356.935 | 163.817 | 0,15% | Hisse senetleri |
| Brandywine Global Investment Management, LLC | $45.181.831 | 133.773 | 0,14% | Hisse senetleri |
| Asset Management One Co., Ltd. | $44.176.566 | 140.627 | 0,14% | Hisse senetleri |
| Trajan Wealth LLC | $43.325.888 | 153.106 | 0,14% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43.248.965 | 152.834 | 0,14% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $42.869.206 | 151.492 | 0,14% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $42.457.470 | 150.037 | 0,14% | Hisse senetleri |
| UBS Group AG | $41.937.353 | 148.199 | 0,13% | Hisse senetleri |
| Freestone Grove Partners LP | $41.195.379 | 145.577 | 0,13% | Hisse senetleri |
| Qube Research & Technologies Ltd | $40.558.109 | 143.325 | 0,13% | Hisse senetleri |
| VAN ECK ASSOCIATES CORP | $40.356.344 | 142.612 | 0,13% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $40.057.234 | 141.555 | 0,13% | Hisse senetleri |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38.839.791 | 137.253 | 0,12% | Hisse senetleri |
| ROYAL BANK OF CANADA | $37.959.000 | 134.139 | 0,12% | Hisse senetleri |
Şirket yöneticileri 49 içeriden öğrenenler · 23 yöneticiler · 27 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 18 Haziran 2025 M | 44.094 | 0 | 0 | $0 |
| David R Yost | CEO | 17 Mayıs 2011 M | 1.530.341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29 Haziran 2026 A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 09 Kasım 2018 M | 53.505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 02 Mayıs 2011 M | 89.698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15 Şubat 2007 A | 176.400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 30 Haziran 2026 A | 30.756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 30 Haziran 2026 A | 23.624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16 Eylül 2025 M | 305.913 | 0 | 2 | $-13.314.729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 29 Mayıs 2025 S | 17.154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28 Haziran 2024 A | 9.525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31 Mayıs 2024 S | 13.284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20 Aralık 2021 G | 81.367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21 Şubat 2020 M | 6.906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23 Mayıs 2019 S | 1.085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 04 Nisan 2018 M | 47.989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17 Kasım 2017 F | 3.010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 09 Kasım 2016 A | 34.195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29 Nisan 2016 F | 8.897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13 Kasım 2015 F | 5.224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13 Kasım 2015 M | 4.068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 01 Şubat 2010 M | 27.190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27 Şubat 2008 A | 25.728 | 0 | 0 | $0 |
| Lauren M Tyler | Yönetim kurulu üyesi | 31 Temmuz 2026 A | 4.456 | 1 | 0 | $148.626 |
| Dennis M Nally | Yönetim kurulu üyesi | 31 Temmuz 2026 A | 13.188 | 0 | 0 | $0 |
| Ellen Cooper | Yönetim kurulu üyesi | 31 Temmuz 2026 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Yönetim kurulu üyesi | 18 Haziran 2026 P | 31.767 | 2 | 0 | $2.161.800 |
| Lori Ryerkerk | Yönetim kurulu üyesi | 01 Temmuz 2025 A | 516 | 0 | 0 | $0 |
| Werner Baumann | Yönetim kurulu üyesi | 01 Mayıs 2025 A | 2.896 | 0 | 0 | $0 |
| Redonda Miller | Yönetim kurulu üyesi | 06 Mart 2025 A | 3.194 | 0 | 0 | $0 |
| Frank Clyburn | Yönetim kurulu üyesi | 06 Mart 2025 A | 1.157 | 0 | 0 | $0 |
| Lorence H. Kim | Yönetim kurulu üyesi | 06 Mart 2025 A | 3.524 | 0 | 0 | $0 |
| Richard W Gochnauer | Yönetim kurulu üyesi | 11 Mart 2024 M | 28.762 | 0 | 0 | $0 |
| Kathleen W Hyle | Yönetim kurulu üyesi | 11 Mart 2024 M | 24.406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Yönetim kurulu üyesi | 09 Mart 2023 A | 20.479 | 0 | 0 | $0 |
| Jane E Henney MD | Yönetim kurulu üyesi | 05 Mart 2023 M | 24.685 | 0 | 0 | $0 |
| Michael J Long | Yönetim kurulu üyesi | 05 Mart 2023 M | 17.724 | 0 | 0 | $0 |
| Douglas R Conant | Yönetim kurulu üyesi | 04 Mart 2019 M | 8.062 | 0 | 0 | $0 |
| Richard C Gozon | Yönetim kurulu üyesi | 29 Şubat 2016 M | 51.484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Yönetim kurulu üyesi | 02 Mart 2015 M | 3.351 | 0 | 0 | $0 |
| Charles H Cotros | Yönetim kurulu üyesi | 07 Aralık 2012 M | 26.773 | 0 | 0 | $0 |
| Lawrence J Wilson | Yönetim kurulu üyesi | 01 Mayıs 2009 A | 35.942 | 0 | 0 | $0 |
| Rodney H Brady | Yönetim kurulu üyesi | 19 Şubat 2007 A | 52.746 | 0 | 0 | $0 |
| James R Mellor | Yönetim kurulu üyesi | 03 Ocak 2006 M | 32.246 | 0 | 0 | $0 |
| Robert E Martini | Yönetim kurulu üyesi | 23 Ocak 2004 G | 1.602.739 | 0 | 0 | $0 |
| Francis G Rodgers | Yönetim kurulu üyesi | 03 Kasım 2003 A | 7.918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | 10% sahip | 31 Temmuz 2007 J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 11 Mart 2026 M | 160.357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 05 Mart 2026 A | 18.408 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 başvurular | 09 Haziran 2025 | 4,96% | Değişiklik | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23 Ocak 2015 | — | İlk başvuru | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 başvurular | 16 Ocak 2015 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 212 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3,11% | 1.841 NS | 30 Nisan 2026 | N-PORT |
| IYK · iShares Trust | 2,76% | 121.004 SH | 08 Ağustos 2026 | Günlük |
| FXG · First Trust Exchange-Traded AlphaDE… | 2,40% | 19.060 NS | 30 Nisan 2026 | N-PORT |
| PAWZ · ProShares Trust | 2,36% | 2.847 NS | 31 Mayıs 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,34% | 1.750 NS | 31 Mayıs 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,26% | 12.908 SH | 08 Ağustos 2026 | Günlük |
| MEDI · Harbor ETF Trust | 2,16% | 1.935 NS | 30 Nisan 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,91% | 186 NS | 30 Nisan 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,83% | 568.607 SH | 08 Ağustos 2026 | Günlük |
| SWP · Manager Directed Portfolios | 1,75% | 10.059 NS | 31 Mayıs 2026 | N-PORT |
| IWP · iShares Trust | 1,73% | 1.079.322 SH | 08 Ağustos 2026 | Günlük |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 42.128 SH | 08 Ağustos 2026 | Günlük |
| QIDX · Spinnaker ETF Series | 1,66% | 2.065 NS | 30 Nisan 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 30 Nisan 2026 | N-PORT |
| USMV · iShares Trust | 1,29% | 958.985 SH | 08 Ağustos 2026 | Günlük |
| ESMV · iShares Trust | 1,27% | 308 SH | 08 Ağustos 2026 | Günlük |
| UPSD · ETF Series Solutions | 1,21% | 3.966 NS | 30 Nisan 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,17% | 7.354 NS | 30 Nisan 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,17% | 1.161 NS | 30 Nisan 2026 | N-PORT |
| ACWV · iShares, Inc. | 1,17% | 120.628 SH | 08 Ağustos 2026 | Günlük |
| FMAG · FIDELITY COVINGTON TRUST | 1,10% | 9.066 NS | 30 Nisan 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,10% | 73.945 NS | 30 Nisan 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,03% | 608.442 NS | 30 Nisan 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,02% | 1.555 NS | 30 Nisan 2026 | N-PORT |
| GROZ · Zacks Trust | 0,93% | 3.136 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,92% | 84.961 NS | 30 Nisan 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1.187.313 SH | 08 Ağustos 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,86% | 3.879 NS | 30 Nisan 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,85% | 45.117 SH | 08 Ağustos 2026 | Günlük |
| IMCG · iShares Trust | 0,84% | 105.034 SH | 08 Ağustos 2026 | Günlük |
| IXJ · iShares Trust | 0,80% | 102.068 SH | 08 Ağustos 2026 | Günlük |
| ALTL · Pacer Funds Trust | 0,79% | 2.471 NS | 30 Nisan 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 6.030 NS | 30 Nisan 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 555.571 SH | 08 Ağustos 2026 | Günlük |
| PALC · Pacer Funds Trust | 0,76% | 5.696 NS | 30 Nisan 2026 | N-PORT |
| RXL · ProShares Trust | 0,76% | 2.029 NS | 31 Mayıs 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,75% | 285 NS | 31 Mayıs 2026 | N-PORT |
| ROE · EA Series Trust | 0,73% | 7.012 NS | 29 Mayıs 2026 | N-PORT |
| TAX · EA Series Trust | 0,72% | 680 NS | 29 Mayıs 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,68% | 342 NS | 30 Nisan 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,68% | 249.048 NS | 30 Nisan 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,66% | 3.314 NS | 31 Mayıs 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 18.623 SH | 08 Ağustos 2026 | Günlük |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4.005.623 SH | 08 Ağustos 2026 | Günlük |
| QARP · DBX ETF Trust | 0,49% | 1.374 NS | 29 Mayıs 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,47% | 2.120 NS | 31 Mayıs 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,44% | 77.004 NS | 30 Nisan 2026 | N-PORT |
| IWR · iShares Trust | 0,43% | 760.297 SH | 08 Ağustos 2026 | Günlük |
| IMCB · iShares Trust | 0,43% | 22.227 SH | 08 Ağustos 2026 | Günlük |
| JSTC · Tidal Trust I | 0,40% | 4.993 NS | 31 Mayıs 2026 | N-PORT |